Commonwealth Equity Services’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$304K Sell
19,682
-1,948
-9% -$30.1K ﹤0.01% 3564
2025
Q1
$322K Buy
21,630
+3,916
+22% +$58.3K ﹤0.01% 3433
2024
Q4
$235K Sell
17,714
-2,389
-12% -$31.7K ﹤0.01% 3627
2024
Q3
$286K Sell
20,103
-3,765
-16% -$53.6K ﹤0.01% 3393
2024
Q2
$309K Sell
23,868
-1,827
-7% -$23.7K ﹤0.01% 3262
2024
Q1
$357K Sell
25,695
-3,053
-11% -$42.4K ﹤0.01% 3112
2023
Q4
$410K Buy
28,748
+1,152
+4% +$16.4K ﹤0.01% 2897
2023
Q3
$427K Sell
27,596
-2,760
-9% -$42.7K ﹤0.01% 2723
2023
Q2
$477K Sell
30,356
-4,220
-12% -$66.3K ﹤0.01% 2665
2023
Q1
$569 Sell
34,576
-530
-2% -$9 ﹤0.01% 2444
2022
Q4
$547K Sell
35,106
-30,751
-47% -$479K ﹤0.01% 2398
2022
Q3
$854K Sell
65,857
-2,133
-3% -$27.7K ﹤0.01% 2011
2022
Q2
$954K Sell
67,990
-8,081
-11% -$113K ﹤0.01% 1938
2022
Q1
$1.09M Sell
76,071
-3,103
-4% -$44.4K ﹤0.01% 1926
2021
Q4
$1.08M Sell
79,174
-41,893
-35% -$571K ﹤0.01% 1932
2021
Q3
$1.98M Sell
121,067
-49,029
-29% -$803K 0.01% 1429
2021
Q2
$2.86M Buy
170,096
+31,289
+23% +$526K 0.01% 1189
2021
Q1
$2.53M Buy
138,807
+41,674
+43% +$761K 0.01% 1167
2020
Q4
$1.77M Buy
97,133
+70,039
+259% +$1.27M 0.01% 1293
2020
Q3
$483K Sell
27,094
-3,152
-10% -$56.2K ﹤0.01% 1987
2020
Q2
$542K Sell
30,246
-1,490
-5% -$26.7K ﹤0.01% 1822
2020
Q1
$481K Sell
31,736
-3,959
-11% -$60K ﹤0.01% 1722
2019
Q4
$704K Buy
35,695
+1,767
+5% +$34.9K ﹤0.01% 1651
2019
Q3
$583K Buy
33,928
+8,328
+33% +$143K ﹤0.01% 1719
2019
Q2
$453K Sell
25,600
-9,967
-28% -$176K ﹤0.01% 1879
2019
Q1
$724K Buy
+35,567
New +$724K ﹤0.01% 1507